Regen BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jan '26 Jan 15, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	2016 - 2020
Market Capitalization	1	1	1	6	33	130	Upgrade
Market Cap Growth	-66.75%	-48.33%	-83.75%	-80.65%	-74.88%	59229.10%	Upgrade
Enterprise Value	2	2	2	7	34	132	Upgrade
Last Close Price	0.01	0.01	0.10	0.90	4.88	22.82	Upgrade
PE Ratio	-	-	-	6.18	14.69	-	Upgrade
PS Ratio	2.74	2.25	4.35	26.75	138.87	760.54	Upgrade
PB Ratio	-0.10	-0.08	-0.20	-1.24	-4.07	-9.65	Upgrade
EV/Sales Ratio	7.51	6.62	7.13	29.34	145.32	773.60	Upgrade
Debt / Equity Ratio	-0.19	-0.19	-0.15	-0.15	-0.16	-0.27	Upgrade
Asset Turnover	1.09	1.09	0.92	0.52	0.27	0.26	Upgrade
Quick Ratio	0.04	0.04	0.02	0.02	0.04	0.06	Upgrade
Current Ratio	0.04	0.04	0.03	0.03	0.04	0.07	Upgrade
Return on Assets (ROA)	-97.12%	-97.12%	-101.33%	-94.09%	-23.97%	-18.79%	Upgrade
Return on Capital Employed (ROCE)	5.40%	5.40%	8.00%	13.90%	4.20%	1.50%	Upgrade
Earnings Yield	-196.58%	-239.77%	-64.96%	18.27%	7.47%	-5.20%	Upgrade
Buyback Yield / Dilution	-472.27%	-472.27%	41.90%	-12.79%	-56.19%	-113.61%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.